Companies

Aarti Drugs Q3 net dips 10% at Rs 20.89 cr

PTI New Delhi | Updated on February 11, 2019 Published on February 11, 2019

Drug firm Aarti Drugs reported a 10.45 per cent dip in its consolidated net profit to Rs 20.89 crore.

Drug firm Aarti Drugs on Monday reported a 10.45 per cent dip in its consolidated net profit to Rs 20.89 crore for the quarter ended December 31, 2018.

The company had posted a net profit of Rs 23.33 crore for the corresponding period of the previous fiscal, Aarti Drugs said in a filing to BSE.

Consolidated revenue from operations of the company however stood at Rs 380.11 crore for the quarter under consideration as against Rs 335.41 crore for October-December 2017.

Shares of Aarti Drugs closed at Rs 592.70 on BSE, up 1.50 per cent from the previous close.

Published on February 11, 2019
This article is closed for comments.
Please Email the Editor